Importantly, post-mortem analyses of BDNF brain content do indicate correlations between brain levels of BDNF and the rate of cognitive decline in diseases such as Alzheimer’s or Parkinson’s (Howells et al., 2000; Buchman et al., 2016) and in depression (Thompson Ray et al., 2011). This evidence concerns the gene BDNF and Parkinsonism.